Fast Assay for Pathogen Identification and Characterization - Prospective Study (FAPIC)
Sponsor: AIT Austrian Institute of Technology GmbH
Listed as NCT03025802, this observational or N/A phase trial focuses on Sepsis and remains completed. Sponsored by AIT Austrian Institute of Technology GmbH, it has been updated 10 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 5 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed
Status: Not Yet Recruiting → Completed
-
May 2018 — Jun 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — May 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
-
Feb 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AIT Austrian Institute of Technology GmbH
- Hasselt University
- Jessa Hospital
- University of Zagreb
For direct contact, visit the study record on ClinicalTrials.gov .